Failed 2025

    Miga Health

    Virtual specialty clinics live or die on payer contracts. If your CPT-code strategy isn't proven in year one, your Series A math is fiction.

    TL;DR — Failure Post-Mortem

    Miga Health was a Digital Health / Cardiovascular startup founded in 2021 in USA. It raised $26M before collapsing in 2025 — 4 years of runway burned. IdeaProof's AI Failure Score: 54/100, driven by virtual specialty care model couldn't clear payer reimbursement thresholds. The shutdown affected employees, investors, and the broader Digital Health / Cardiovascular ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.

    Why did Miga Health fail?

    Miga Health failed in 2025 after 4 years of operation, losing $26M in raised capital. The root cause was virtual specialty care model couldn't clear payer reimbursement thresholds. Key lesson: Virtual specialty clinics live or die on payer contracts. If your CPT-code strategy isn't proven in year one, your Series A math is fiction.

    Verifiable facts
    Sourced
    Founded → Closed

    2021 → 2025

    Funding Raised

    $26M

    Industry

    Digital Health / Cardiovascular

    Country

    USA

    IdeaProof AI Failure Score

    54/100
    Market Fit Risk
    55
    Burn Rate Risk
    60
    Founder Risk
    45

    What Happened: The Timeline

    🚀

    2021

    Miga Health founded in USA. Positioned in digital health / cardiovascular.

    💰

    2021-2023

    Raises $26M from 7wireVentures, Define Ventures, Redesign Health.

    ⚠️

    2024

    Warning signs emerge: payer contracts stalled at pilot scale.

    💀

    2025

    Shutdown announced. Root cause: virtual specialty care model couldn't clear payer reimbursement thresholds.

    Root Causes

    Miga Health was a Denver-based virtual cardiovascular care startup incubated by Redesign Health and backed by 7wireVentures and Define Ventures. It raised roughly $26M to offer remote heart-health management combining wearables, coaching and cardiologist visits. In March 2025 Endpoints News reported the company had quietly stopped taking new patients and was winding down. The core issue was reimbursement: payer contracts for virtual specialty cardiology never scaled beyond pilot programs, and per-member-per-month rates fell below the cost of clinician time. Miga is one of a wave of virtual specialty startups (Cerebral for psych, Firefly for primary, Ro for men's health) hitting the payer reimbursement ceiling.

    Causal Chain

    Derived · heuristic

    This is our reading of the causal chain — separated from the verifiable facts above. Timeline dates, funding numbers and filings are facts (see methodology); root / proximate / terminal attribution is judgement based on public evidence.

    Root cause

    A combination of demand-side, execution, and capital-market pressures that this record documents without isolating a single dominant driver.

    Contributing factors
    • Payer contracts stalled at pilot scale
    • PMPM economics upside-down
    • Wearable data didn't drive enough intervention revenue
    • Category leader Livongo/Teladoc absorbed enterprise buyers
    Proximate cause

    2024: Warning signs emerge: payer contracts stalled at pilot scale.

    Terminal event

    2025: Shutdown announced. Root cause: virtual specialty care model couldn't clear payer reimbursement thresholds.

    Base rates

    External sources

    A single failure is an anecdote. These base rates give you the denominator — how common this outcome is across all startups matching Miga Health's profile. Sources are third-party; we do not restate them as our own claims.

    ~70%
    industry

    of digital-health startups fail to reach breakeven; reimbursement complexity + regulatory approvals extend runway needs beyond typical VC horizons.

    Rock Health State of Digital Health (2023)
    ~90%
    all

    of startups ultimately fail — including ~10% that fail in the first year and the rest across the following decade.

    Startup Genome / CB Insights aggregate (2024)
    ~35%
    all

    of new US employer businesses survive past their 10th year (Bureau of Labor Statistics BED series).

    US Bureau of Labor Statistics — BED (2024)
    ~35%
    stage

    of Series A rounds ever graduate to Series B; the rest run out of runway or pivot without a follow-on.

    CB Insights Venture Capital Funnel (2023)

    Key Lessons Learned

    1. Payer contracts stalled at pilot scale

    Payer contracts stalled at pilot scale — a recurring pattern across digital health / cardiovascular failures. Validate this risk before you scale.

    2. PMPM economics upside-down

    PMPM economics upside-down — a recurring pattern across digital health / cardiovascular failures. Validate this risk before you scale.

    3. Wearable data didn't drive enough intervention revenue

    Wearable data didn't drive enough intervention revenue — a recurring pattern across digital health / cardiovascular failures. Validate this risk before you scale.

    Frequently Asked Questions

    Sources & Confidence

    Every data point is tagged with its source type and our confidence in it. How we grade sources.

    Additional references

    Could This Failure Have Been Prevented?

    IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Miga Health.

    Spotted a factual error?

    Approved corrections are published in the public changelog with attribution.